The Ministry of Health has already distributed the first doses of the new Pfizer vaccine updated to subvariant XBB.1.5. of omicron and those of the Catalan Hiprawhich will be given to those whose mRNA sera are contraindicated, so that the communities can start the campaign next week.
Brussels will buy 250 million doses of the Hipra vaccine
This has been informed to EFE by sources from the department headed by José Miñones that, although They have not specified the amount of adapted vaccines that have already been distributed to the autonomous communitiesthey did remember that availability will increase as the season progresses.
A season in which Vaccination against covid and flu will coincide again in those population groups at highest risk of developing these diseases seriously and which were recently outlined by the Public Health Commission in the document “Vaccination recommendations against flu and COVID-19 in the 2023-2024 season in Spain”.
Is about those over 60 and those over 5 years old in disability centers and residences of the elderly, as well as people at risk for suffering from other pathologies such as diabetes, kidney failure, morbid obesity or chronic cardiovascular, neurological or respiratory diseases, pregnant in any trimester of gestation or cohabitants of patients immunocompromisedamong others.
Subvariants of omicron
The aforementioned document, approved on September 12, advises use the new vaccines adapted to the omicron subvariants, “except in particular circumstances.” “In people who are contraindicated for mRNA vaccines against Covid-19, the available protein vaccines can be administered,” she adds.
They detect the omicron subvariant XBB.1.5 on a specific basis in the State
For this season, it is recommended that target groups are vaccinated against covid regardless of the number of doses received previously, even if they have not had any, with an interval of at least 3 months since the last puncture or infection.
Only the target groups because, as the Public Health Commission makes clear, “at this time, considering the epidemiological situation and the immunity acquired by the population, Vaccination against COVID-19 is not justified in people not included“in them.
The set objective is achieve or exceed coverage for both covid and flu of 75% in seniors and health personnel and socio-health, as well as sincrease 60% in pregnant women and in people with risk conditions.
The only one available in the State that is not mRNA is Hipra, called Bimervax, a protein S vaccine of the alpha and beta variants – that is, those prior to omicron – with SQBA5 adjuvant, although “it has demonstrated neutralization capacity against SARS-CoV-2 beta, delta, omicron BA strains .1 and XBB.1.5”, states the text of recommendations.
Health receives 3.2 million doses of the Hipra vaccine
Authorized only as a reinforcement for people over 16 years of age, till the date The Spanish State alone has acquired 3.2 million doses of the 250 million that Brussels agreed with the biotechnology company – a price of between 7 and 9.5 euros each – in a contract signed in August 2022; however, since Health assures that there are other countries interested in having it.
Regarding the updated ones, Pfizer and Moderna -Novavax not yet- they have already approved to be marketed in the EU, but when the document was drafted, only the first one was, which is the one that Health has already distributed.
Comirnaty omicron months, respectively
#Health #distributes #updated #vaccines #Hipra #campaign #covid